NO20053730L - Pyridinderivater anvendelig for hemming av natrium/kalsium-utbyttingssystem - Google Patents
Pyridinderivater anvendelig for hemming av natrium/kalsium-utbyttingssystemInfo
- Publication number
- NO20053730L NO20053730L NO20053730A NO20053730A NO20053730L NO 20053730 L NO20053730 L NO 20053730L NO 20053730 A NO20053730 A NO 20053730A NO 20053730 A NO20053730 A NO 20053730A NO 20053730 L NO20053730 L NO 20053730L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- halogen
- nhc
- group
- ch2nr15r18
- Prior art date
Links
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title 1
- 239000011575 calcium Substances 0.000 title 1
- 229910052791 calcium Inorganic materials 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 150000003222 pyridines Chemical class 0.000 title 1
- 239000011734 sodium Substances 0.000 title 1
- 229910052708 sodium Inorganic materials 0.000 title 1
- 229910052736 halogen Inorganic materials 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 101100240526 Caenorhabditis elegans nhr-20 gene Proteins 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20030030A FI20030030A0 (fi) | 2003-01-09 | 2003-01-09 | Uusia yhdisteitä |
| PCT/FI2004/000011 WO2004063191A1 (en) | 2003-01-09 | 2004-01-09 | Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20053730D0 NO20053730D0 (no) | 2005-08-03 |
| NO20053730L true NO20053730L (no) | 2005-10-07 |
Family
ID=8565286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20053730A NO20053730L (no) | 2003-01-09 | 2005-08-03 | Pyridinderivater anvendelig for hemming av natrium/kalsium-utbyttingssystem |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7482340B2 (pt) |
| EP (1) | EP1583759A1 (pt) |
| JP (1) | JP2006516271A (pt) |
| KR (1) | KR20050095601A (pt) |
| CN (1) | CN100457752C (pt) |
| AR (1) | AR042733A1 (pt) |
| AU (1) | AU2004203943B2 (pt) |
| BR (1) | BRPI0406669A (pt) |
| CA (1) | CA2512184A1 (pt) |
| EA (1) | EA008539B1 (pt) |
| FI (1) | FI20030030A0 (pt) |
| HR (1) | HRP20050703A2 (pt) |
| IL (1) | IL169435A0 (pt) |
| IS (1) | IS7969A (pt) |
| MX (1) | MXPA05007435A (pt) |
| NO (1) | NO20053730L (pt) |
| NZ (1) | NZ541087A (pt) |
| PL (1) | PL378326A1 (pt) |
| RS (1) | RS20050528A (pt) |
| UA (1) | UA81941C2 (pt) |
| WO (1) | WO2004063191A1 (pt) |
| ZA (1) | ZA200505461B (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20011507A0 (fi) * | 2001-07-10 | 2001-07-10 | Orion Corp | Uusia yhdisteitä |
| KR101233223B1 (ko) * | 2004-12-21 | 2013-02-14 | 제이엔씨 석유 화학 주식회사 | 크로만환을 가지는 액정 화합물, 액정 조성물 및 이 액정조성물을 함유하는 액정 표시소자 |
| JP2010519267A (ja) * | 2007-02-22 | 2010-06-03 | シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト | 新規殺微生物剤 |
| EP2649066B1 (en) * | 2010-12-06 | 2015-10-21 | Autifony Therapeutics Limited | Hydantoin derivatives useful as kv3 inhibitors |
| EP2524908A1 (en) * | 2011-05-20 | 2012-11-21 | LEK Pharmaceuticals d.d. | Process for the preparation of alfa-substituted ketones and their application in synthesis of pharmaceutically active compounds |
| US8912224B2 (en) | 2011-09-12 | 2014-12-16 | Sanofi | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
| JP5941637B2 (ja) * | 2011-09-12 | 2016-06-29 | サノフイ | 置換２−（クロマン−６−イルオキシ）−チアゾール及び医薬としてのその使用 |
| SG11201400518RA (en) | 2011-09-12 | 2014-04-28 | Sanofi Sa | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
| RS53748B1 (sr) * | 2011-09-12 | 2015-06-30 | Sanofi | Supstituisani 2-(hroman-6-iloksi)-tiazoli i njihova upotreba kao farmaceutskih sredstava |
| WO2013144191A1 (de) * | 2012-03-29 | 2013-10-03 | Bayer Intellectual Property Gmbh | Substituierte 2 -amino - 3 - cyanopyridine als inhibitoren des natrium calcium austausches und ihre verwendung bei kardiovaskulären erkrankungen |
| TWI633095B (zh) * | 2013-03-08 | 2018-08-21 | 賽諾菲公司 | 經取代－６－基氧基－環烷類及其作為醫藥品之用途 |
| GB201416186D0 (en) | 2014-09-12 | 2014-10-29 | Redx Pharma Ltd | Compounds |
| EP3265445B1 (en) | 2015-03-06 | 2021-05-05 | Pharmakea, Inc. | Lysyl oxidase-like 2 inhibitors and uses thereof |
| AU2016229268B2 (en) | 2015-03-06 | 2020-09-10 | Pharmakea, Inc. | Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof |
| WO2017030169A1 (ja) * | 2015-08-19 | 2017-02-23 | 日産化学工業株式会社 | 液晶配向剤などに用いられる新規なイミド系重合体 |
| CA3036064A1 (en) | 2016-09-07 | 2018-03-15 | Pharmakea, Inc. | Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making |
| WO2018048942A1 (en) | 2016-09-07 | 2018-03-15 | Pharmakea, Inc. | Uses of a lysyl oxidase-like 2 inhibitor |
| WO2019175464A1 (en) | 2018-03-14 | 2019-09-19 | Orion Corporation | Compounds useful as inhibitors of sodium-calcium exchanger (ncx) |
| EP4188552A2 (en) | 2020-07-28 | 2023-06-07 | Jazz Pharmaceuticals Ireland Limited | Fused bicyclic raf inhibitors and methods for use thereof |
| CN115850258B (zh) * | 2022-12-27 | 2024-09-24 | 东北林业大学 | 一种马赛替尼的合成方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2820817A (en) * | 1954-02-04 | 1958-01-21 | Mcneilab Inc | Oxygenated indan compounds and method of making the same |
| US3862232A (en) * | 1963-07-03 | 1975-01-21 | Upjohn Co | 1-(p-hydroxyphenyl)-2-phenyl-6-(2-diethylaminoethoxy)-3,4-dihydronaphthalene and the salts thereof |
| BE650081A (pt) | 1963-07-03 | |||
| GB1154119A (en) | 1968-05-20 | 1969-06-04 | Merck Ag E | 3-Alkyl-Flavanones |
| JPH04113839A (ja) * | 1990-09-05 | 1992-04-15 | Mitsubishi Petrochem Co Ltd | ポリカーボネート樹脂積層物 |
| FR2733685B1 (fr) * | 1995-05-05 | 1997-05-30 | Adir | Utilisation des derives du benzopyrane pour l'obtention de compositions pharmaceutiques destinees au traitement des pathologies liees a l'echangeur c1-/hc03-, na+ independant |
| JPH0967336A (ja) | 1995-09-04 | 1997-03-11 | Kanebo Ltd | 新規なイソチオウレア誘導体 |
| DE69810606T2 (de) | 1997-03-27 | 2003-10-09 | Taisho Pharmaceutical Co., Ltd. | 2-phenoxyanilinderivate |
| JPH1149752A (ja) * | 1997-08-05 | 1999-02-23 | Taisho Pharmaceut Co Ltd | フェノキシピリジン誘導体 |
| DE19742508A1 (de) * | 1997-09-26 | 1999-04-01 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
| DK1031556T3 (da) | 1997-10-20 | 2003-02-24 | Taisho Pharmaceutical Co Ltd | 2-phenoxyanilinderivater |
| JPH11302235A (ja) | 1998-04-15 | 1999-11-02 | Taisho Pharmaceut Co Ltd | フェノキシアルキルアミン誘導体 |
| JP2002542291A (ja) | 1999-04-23 | 2002-12-10 | ブリストル−マイヤーズ スクイブ カンパニー | ジ環式アシルグアニジン・ナトリウム／プロトン交換抑制剤および方法 |
| CA2383583C (en) * | 1999-09-17 | 2009-04-07 | Nissan Chemical Industries, Ltd. | Benzopyran derivative |
| FI20011507A0 (fi) | 2001-07-10 | 2001-07-10 | Orion Corp | Uusia yhdisteitä |
-
2003
- 2003-01-09 FI FI20030030A patent/FI20030030A0/fi unknown
-
2004
- 2004-01-08 AR ARP040100052A patent/AR042733A1/es unknown
- 2004-01-09 CA CA002512184A patent/CA2512184A1/en not_active Abandoned
- 2004-01-09 NZ NZ541087A patent/NZ541087A/en unknown
- 2004-01-09 KR KR1020057012621A patent/KR20050095601A/ko not_active Ceased
- 2004-01-09 RS YUP-2005/0528A patent/RS20050528A/sr unknown
- 2004-01-09 JP JP2006500151A patent/JP2006516271A/ja active Pending
- 2004-01-09 HR HR20050703A patent/HRP20050703A2/hr not_active Application Discontinuation
- 2004-01-09 WO PCT/FI2004/000011 patent/WO2004063191A1/en not_active Ceased
- 2004-01-09 EP EP04701023A patent/EP1583759A1/en not_active Withdrawn
- 2004-01-09 MX MXPA05007435A patent/MXPA05007435A/es active IP Right Grant
- 2004-01-09 US US10/541,677 patent/US7482340B2/en not_active Expired - Fee Related
- 2004-01-09 BR BR0406669-3A patent/BRPI0406669A/pt not_active IP Right Cessation
- 2004-01-09 PL PL378326A patent/PL378326A1/pl not_active Application Discontinuation
- 2004-01-09 EA EA200501104A patent/EA008539B1/ru not_active IP Right Cessation
- 2004-01-09 AU AU2004203943A patent/AU2004203943B2/en not_active Ceased
- 2004-01-09 CN CNB200480003357XA patent/CN100457752C/zh not_active Expired - Fee Related
- 2004-09-01 UA UAA200507847A patent/UA81941C2/uk unknown
-
2005
- 2005-06-28 IL IL169435A patent/IL169435A0/en unknown
- 2005-08-02 IS IS7969A patent/IS7969A/is unknown
- 2005-08-03 NO NO20053730A patent/NO20053730L/no not_active Application Discontinuation
-
2006
- 2006-01-24 ZA ZA200505461A patent/ZA200505461B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050095601A (ko) | 2005-09-29 |
| PL378326A1 (pl) | 2006-03-20 |
| JP2006516271A (ja) | 2006-06-29 |
| HRP20050703A2 (en) | 2005-10-31 |
| AU2004203943B2 (en) | 2009-09-17 |
| FI20030030A0 (fi) | 2003-01-09 |
| UA81941C2 (uk) | 2008-02-25 |
| MXPA05007435A (es) | 2005-09-12 |
| BRPI0406669A (pt) | 2005-12-20 |
| CN1745078A (zh) | 2006-03-08 |
| ZA200505461B (en) | 2006-03-29 |
| NO20053730D0 (no) | 2005-08-03 |
| EA008539B1 (ru) | 2007-06-29 |
| RS20050528A (sr) | 2007-06-04 |
| IS7969A (is) | 2005-08-02 |
| US20060241147A1 (en) | 2006-10-26 |
| EA200501104A1 (ru) | 2005-12-29 |
| WO2004063191A1 (en) | 2004-07-29 |
| CN100457752C (zh) | 2009-02-04 |
| EP1583759A1 (en) | 2005-10-12 |
| AU2004203943A1 (en) | 2004-07-29 |
| NZ541087A (en) | 2008-04-30 |
| CA2512184A1 (en) | 2004-07-29 |
| IL169435A0 (en) | 2007-07-04 |
| AR042733A1 (es) | 2005-06-29 |
| US7482340B2 (en) | 2009-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20053730L (no) | Pyridinderivater anvendelig for hemming av natrium/kalsium-utbyttingssystem | |
| TW434227B (en) | Novel N-benzylindole and benzopyrazole derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immune modulating effect | |
| ES2388917T3 (es) | Compuestos de benzamida sustituidos con actividad antihipertensiva | |
| EP0747368B1 (en) | Derivatives of monocyclic polyamines, their preparation, and their use as antiviral agents | |
| AU704839B2 (en) | The use of heterocyclic compounds | |
| WO2004026841A1 (ja) | 新規６−置換ウラシル誘導体及びアレルギー性疾患の治療剤 | |
| JP6441831B2 (ja) | カテプシンｃの置換２−アザ−ビシクロ［２．２．２］オクタン−３−カルボン酸（ベンジル−シアノ−メチル）−アミド阻害剤 | |
| WO2009074749A2 (fr) | Dérives de nicotinamide. leur préparation et leur application en thérapeutique | |
| PT1979331E (pt) | Compostos de amina trissubstituída como inibidores da proteína de transferência de éster de colesterilo | |
| BR122017003188A2 (pt) | composto 1-{2-[4-(2-amino-5-cloro-3-piridinil)fenóxi]-5-pirimidinil}-3-[2-(metilsulfonil)-5-(trifluorometil)fenil]ureia, sal deste, composição farmacêutica compreendendo-os e uso destes para o tratamento de câncer | |
| EP2411368A1 (fr) | Derives de nicotinamide, leur preparation et leur application en therapeutique comme anticancereux | |
| IL177291A0 (en) | Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists | |
| TW200307545A (en) | Nicotinamide derivatives and a tiotropium salt in combination for the treatment of diseases | |
| JP2016510785A (ja) | カテプシンｃの置換二環式１−カルボン酸（ベンジル−シアノ−メチル）−アミド阻害剤 | |
| HUT67666A (en) | Biphenylil methyl pyrimidine derivatives having angiotensine ii antagonistic activity and pharmaceutical compositions containing them | |
| AU658729B2 (en) | 3-(1H-imidazol-1-ylmethyl)-1H-indole derivatives | |
| NO20074622L (no) | Metabolitter for NK-1 antagonister for brekninger | |
| JP2993316B2 (ja) | アリール基又は複素芳香環基置換アミノキノロン誘導体及びエイズ治療剤 | |
| CN101463014A (zh) | 二芳基苯并嘧啶类衍生物及其制备方法和用途 | |
| AU2013261735B2 (en) | Methanethione compounds having antiviral activity | |
| EA200001009A1 (ru) | Производные пиридина, ингибирующие фосфодиэстеразу iv | |
| US6720327B2 (en) | Lactone integrin antagonists | |
| KR960000884A (ko) | 신규의 피리딜 n-옥사이드로 치환된 피리딜이미다졸 유도체 및 그의 제조방법 | |
| NO983831D0 (no) | Nye substituerte N-metyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer | |
| JPS6038351A (ja) | 新規な医薬用化合物及びその調製 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |